TraceLink Expands Life Sciences Expertise With Former Industry Experts From GlaxoSmithKline, AMGEN and Abbott

20:00 EDT 21 Jul 2015 | Marketwired

NORTH READING, MA -- (Marketwired) -- 07/22/15 --
TraceLink Inc., the world's largest track and trace network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced that it has added three pharmaceutical industry veterans to the company's growing roster of Life Sciences personnel with deep expertise in product traceability, global serialization, and supply chain transformation. These industry experts are the latest to join the rapidly expanding TraceLink team of 153 employees -- which has increased by more than 80% since January 1, 2015.

With eight decades of combined experience spanning three of the world's top pharmaceutical brands, the new additions to the TraceLink team include:

"A core component of our growth strategy is to build an organization with deeper domain expertise than any other track and trace solution provider," said Shabbir Dahod, president and CEO of TraceLink. "The eight decades of combined pharmaceutical expertise that Michael, Elizabeth and Marcel bring to TraceLink adds to the vast knowledgebase we've been building that includes tenured professionals who have dedicated their careers to solving complex traceability challenges in Life Sciences. No other solutions provider can outpace the stable of domain experts that we're assembling at TraceLink, and our commitment to serve the Life Sciences industry with talent that comes directly from the industry itself."

To learn more about TraceLink, the Life Sciences Cloud or how to build a flexible, cost-effective global serialization, track and trace, and reporting platform, visit

About TraceLink
TraceLink protects patients, enables health and ensures compliance for companies across the global Life Sciences supply network, including 16 of the top-20 global pharmaceutical companies. Leading businesses trust the TraceLink Life Sciences Cloud, our Amazon AWS-based cloud application platform, to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit or follow us on LinkedIn, Twitter and Facebook.

TraceLink is funded by FirstMark Capital, Volition Capital and Fidelity Biosciences.

Laura MacSweeney Red Javelin Communications (781) 395-6420 NEXT ARTICLE

More From BioPortfolio on "TraceLink Expands Life Sciences Expertise With Former Industry Experts From GlaxoSmithKline, AMGEN and Abbott "

Quick Search


Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...